Muscle Abnormalities in Four Patients Taking Statins To Treat Unfavorable Cholesterol Levels. Ann Intern Med. 2002;137:I-45. doi: 10.7326/0003-4819-137-7-200210010-00004
Download citation file:
Published: Ann Intern Med. 2002;137(7):I-45.
Statins, also known as HMG coenzyme A reductase inhibitors, are medications commonly used to treat high cholesterol levels. Statins are very effective in getting cholesterol levels into the desired range, and they have had few side effects. However, statins do cause a muscle condition called myopathy. In fact, one statin (cerivastatin) was taken off the market because patients frequently developed myopathy while taking it. Patients with myopathy have muscle tenderness and weakness. Measuring blood levels of the muscle protein called creatine kinase helps doctors to diagnose myopathy because in patients with muscle damage, the protein leaks out of muscle cells and into the blood. Some patients receiving statins develop muscle pain and weakness but have normal serum creatine kinase levels. Doctors have been wondering whether these symptoms represent milder forms of muscle damage related to statins.
The researchers report four cases of myopathy associated with statins in patients with normal creatine kinase levels.
While doing a larger study of muscle symptoms in patients taking statins, the researchers found four patients with muscle pain and weakness during statin therapy that went away when the patients stopped taking the statins. All four patients had normal creatine kinase levels.
As part of the larger study, the researchers gave the patients statin or placebo and asked the patients to guess which they were taking. The placebo was a pill that looked, smelled, and tasted like statin but contained no active ingredient. All patients had strength testing. In three of the four patients, the doctors took samples of muscle to examine under a microscope (muscle biopsy) both during and after statin therapy.
The patients could correctly guess when they were taking statins because they developed muscle pain and weakness during that therapy. Strength testing showed muscle weakness when the patients were taking statins and normal strength when they were not taking statins. Muscle biopsy samples obtained when patients were taking statins showed changes of myopathy. These changes were not present on the samples taken after the patients stopped statins.
This study does not tell us anything about how frequently statin-associated myopathy with normal creatine kinase levels occurs.
When patients taking statins develop muscle pain and weakness, they may have muscle damage even if blood test results are normal. More research is necessary to learn how frequently patients taking statins develop myopathy with normal creatine kinase levels.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Cardiology, Dyslipidemia, Coronary Risk Factors.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only